FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 90 filers reported holding FATE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $195 | -92.4% | 91,864 | -82.9% | 0.01% | -91.9% |
| Q2 2023 | $2,555 | +17.8% | 536,831 | +41.1% | 0.11% | +8.8% |
| Q1 2023 | $2,169 | -99.7% | 380,537 | +1681.9% | 0.10% | +88.9% |
| Q1 2022 | $828,000 | +55.3% | 21,356 | +134.4% | 0.05% | -19.4% |
| Q4 2021 | $533,000 | +13.6% | 9,111 | +15.0% | 0.07% | +8.1% |
| Q3 2021 | $469,000 | +172.7% | 7,921 | -54.9% | 0.06% | +87.9% |
| Q1 2018 | $172,000 | -38.6% | 17,580 | -75.1% | 0.03% | -48.4% |
| Q3 2017 | $280,000 | -15.4% | 70,677 | -30.8% | 0.06% | -31.2% |
| Q2 2017 | $331,000 | – | 102,169 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |